A lot of what’s being said lately mixes partial
Post# of 88045
(Total Views: 134)
Posted On: 10/11/2025 4:57:49 PM
A lot of what’s being said lately mixes partial truths with assumptions, so let’s clear up a few things for everyone’s understanding.
When UNVC merges with Dr. Dalton’s private companies, those private companies already have their own financial records and most likely internal or external audits. Those are not public because the companies are private—they only become part of public disclosure after the merger is finalized. UNVC, as the public shell, only needs to file public disclosure of the merger once it’s completed and effective. The private companies being merged in must have credible financials (audited or ready to be audited), but that audit does not have to appear on OTC Markets until after the transaction closes. Once the merger is complete, the combined company will produce consolidated financials. That’s when an official audit covering both sides becomes relevant for uplisting or formal filings later.
So no, UNVC doesn’t have to have a new PCAOB audit before a reverse merger. The private companies’ financials can remain private until the merger closes, and the post-merger entity will undergo the audit and report it when appropriate—especially if the goal is OTCQB or NASDAQ down the line.
As for the claim that the “time frame has passed” for uplisting—that’s false. There is no rule that says an uplist must happen by a certain month or deadline. A company can file for OTCQB at any time once eligibility criteria are met, and many CEOs strategically wait until after a merger to uplist so the stronger, combined financials define the valuation.
The cost estimates of $100K to $500K for an audit are generic numbers used for small OTC startups with no infrastructure. We’re dealing with an operation that has already handled hundreds of millions in revenue and partnerships across healthcare networks. Assuming Dr. Dalton hasn’t already accounted for these costs makes no sense—he’s operated at a level where that kind of expenditure is routine.
Finally, under the Alternative Reporting Standard, UNVC is required to release news of material events like mergers or acquisitions within four business days of finalization—not while in negotiation. Silence in this phase is not secrecy or inaction; it’s compliance and timing. Once finalized, it must be made public, and that’s when it will appear.
So while some are reading this as a sign that nothing is happening, the truth is quite the opposite. The structure is being built privately, as it should be. These steps take time, precision, and confidentiality—not daily noise. Optimism isn’t blind when it’s based on process, experience, and reality.
When UNVC merges with Dr. Dalton’s private companies, those private companies already have their own financial records and most likely internal or external audits. Those are not public because the companies are private—they only become part of public disclosure after the merger is finalized. UNVC, as the public shell, only needs to file public disclosure of the merger once it’s completed and effective. The private companies being merged in must have credible financials (audited or ready to be audited), but that audit does not have to appear on OTC Markets until after the transaction closes. Once the merger is complete, the combined company will produce consolidated financials. That’s when an official audit covering both sides becomes relevant for uplisting or formal filings later.
So no, UNVC doesn’t have to have a new PCAOB audit before a reverse merger. The private companies’ financials can remain private until the merger closes, and the post-merger entity will undergo the audit and report it when appropriate—especially if the goal is OTCQB or NASDAQ down the line.
As for the claim that the “time frame has passed” for uplisting—that’s false. There is no rule that says an uplist must happen by a certain month or deadline. A company can file for OTCQB at any time once eligibility criteria are met, and many CEOs strategically wait until after a merger to uplist so the stronger, combined financials define the valuation.
The cost estimates of $100K to $500K for an audit are generic numbers used for small OTC startups with no infrastructure. We’re dealing with an operation that has already handled hundreds of millions in revenue and partnerships across healthcare networks. Assuming Dr. Dalton hasn’t already accounted for these costs makes no sense—he’s operated at a level where that kind of expenditure is routine.
Finally, under the Alternative Reporting Standard, UNVC is required to release news of material events like mergers or acquisitions within four business days of finalization—not while in negotiation. Silence in this phase is not secrecy or inaction; it’s compliance and timing. Once finalized, it must be made public, and that’s when it will appear.
So while some are reading this as a sign that nothing is happening, the truth is quite the opposite. The structure is being built privately, as it should be. These steps take time, precision, and confidentiality—not daily noise. Optimism isn’t blind when it’s based on process, experience, and reality.
(5)
(0)